KASMEJ

Kastamonu Medical Journal regularly publishes internationally qualified issues in the field of Medicine in the light of up-to-date information.

EndNote Style
Index
Case Report
Unusual cervical involvement in psoriatic arthritis and the presence of cervical and facial dystonia: a case report
Psoriatic arthritis (PsA) exhibits the most prevalent occurrence of cervical spine involvement within the spondyloarthropathies. The disease can progress and cause C1-C2 arthritis, erosions of the odontoid process, atlantoaxial instability, syndesmophytes, ankylosis, osteitis, ossifications, and compression of the spinal cord. Dystonia is a neurological movement disorder that causes involuntary and prolonged muscle contractions, twisting, repetitive movements, and atypical body positions. The occurrence of atlantoaxial distention and degeneration may be observed as a consequence of cervical dystonia, potentially leading to the development of cervical dystonia. This report presents a clinical case of an individual afflicted with PsA as well as cervical and facial dystonia, which includes the manifestation of atlantoaxial degeneration and pannus formation. The case was successfully managed through the administration of secukinumab and botulinum toxin injections.


1. Coates LC, Helliwell PS. Psoriatic arthritis: state of the art review. Clin Med (Lond). 2017;17(1):65-70.
2. Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arth Rheum. 2006;54(8):2665-2673.
3. Queiro R, Sarasqueta C, Torre JC, Tinture T, López-Lagunas I. Prevalence and predictors of cervical involvement in psoriatic spondyloarthropathy. J Clin Rheumatol. 2002;8(1):23-29.
4. Scarpa R. Discovertebral erosions and destruction in psoriatic arthritis. J Rheumatol. 2000;27(4):975-978.
5. Giovannini I, Zabotti A, Cicciò C, et al Axial psoriatic disease: clinical and imaging assessment of an underdiagnosed condition. J Clin Med. 2021; 10(13):2845.
6. Salvarani C, Macchioni P, Cremonesi T, et al. The cervical spine in patients with psoriatic arthritis: A clinical, radiological and immunogenetic study. Ann Rheum Dis. 1992;51(1):73-77.
7. Sallés M, Clavaguera T, Mínguez S, Valencoso O, Lopez de Recalde M, Tuneu R. Atlantoaxial rotatory dislocation in a patient with psoriatic spondyloarthritis. Joint Bone Spine. 2019;86(4):519-521.
8. Singh JA, Guyatt G, Ogdie A, et al. Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the treatment of psoriatic arthritis. Arth Rheumatol. 2019;71(1):25-32.
9. Gerriets V, Goyal A, Khaddour K. Tumor Necrosis Factor Inhibitors. In: StatPearls. Treasure Island (FL): StatPearls Publishing; July 3, 2023.
10. Ha AD, Jankovic J. Parkinsonism and dystonia associated with adalimumab. Mov Disord. 2011;26(8):1556-1558.
11. Peter I, Dubinsky M, Bressman S, et al. Anti-tumor necrosis factor therapy and incidence of parkinson disease among patients with inflammatory bowel disease. JAMA Neurol. 2018;75(8):939-946.
12. Chan J, Brin MF, Fahn S. Idiopathic cervical dystonia: clinical characteristics. Mov Disord. 1991;6(2):119-126.
13. Mercan FN, Akbostancı MC. Cervical dystonia and botulinum toxin treatment: when? Where? How Much? Turk Klin J Neurol-Special Topics. 2013;6(4):16-25.
14. Chu EC, Lo FS, Bhaumik A. Secondary atlantoaxial subluxation in isolated cervical dystonia-a case report. AME Case Rep. 2020;4:9.
15. Tonomura Y, Kataoka H, Sugie K, et al. Atlantoaxial rotatory subluxation associated with cervical dystonia. Spine (Phila Pa 1976). 2007;32(19): E561-E564.
16. Neeraja K, Prasad S, Surisetti BK, et al. Cervical myeloradiculopathy and atlantoaxial instability in cervical dystonia. World Neurosurg. 2021;146:e1287-e1292.
17. Kameda-Smith M, Biswas A, D’Arco F, Thompson D. Os odontoideum and craniovertebral junction instability secondary to dystonia: case series and review of the literature. Eur Spine J. 2024;33(3):1164-1170.
18. Masahiro K, Hidekazu T, Yutaka I, et al. Regression of retro-odontoid pseudotumor following Botulinum injection into cervical muscles. Surg Neurol Int. 2022;13:321.
19. Albanese A, Di Giovanni M, Lalli S. Dystonia: diagnosis and management. Eur J Neurol. 2019;26(1):5-17.
20. Mittal SO, Lenka A, Jankovic J. Cervical dystonia: an update on therapeutics. Expert Opin Orphan Drugs. 2019;7(4):1-11.
Volume 4, Issue 3, 2024
Page : 128-130
_Footer